Netcompany Group A/S (CPH:NETC)
Denmark · Delayed Price · Currency is DKK | Market Cap | 11.09B |
| Revenue (ttm) | 6.69B |
| Net Income (ttm) | 498.50M |
| Shares Out | 47.12M |
| EPS (ttm) | 10.28 |
| PE Ratio | 22.89 |
| Forward PE | 16.15 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 123,329 |
| Average Volume | 84,722 |
| Open | 238.00 |
| Previous Close | 238.00 |
| Day's Range | 233.80 - 239.60 |
| 52-Week Range | 229.20 - 375.80 |
| Beta | 1.17 |
| RSI | 24.12 |
| Earnings Date | Aug 14, 2025 |
About Revance Therapeutics
Netcompany Group A/S, provides business critical IT solutions to private and public customers in Denmark, Norway, the United Kingdom, the Netherlands, Greece, Belgium, Luxembourg, and internationally. The company provides various platforms, such as PULSE, a deployment platform for AI models in operational contexts centered around a real-time data fabric for planning and managing disruptions; AMPLIO, a platform applicable to all case management domains, supporting transitions to modern IT infrastructure; AMI, a platform that enables authorities ... [Read more]
Financial Performance
In 2024, Netcompany Group's revenue was 6.54 billion, an increase of 7.60% compared to the previous year's 6.08 billion. Earnings were 470.20 million, an increase of 54.93%.
Financial StatementsNews
Europe panics as US-Russia talks on Ukraine race ahead without them
Also in this newsletter: Netcompany chief urges Europe to take advantage of ‘digital awakening’